Alamar Biosciences, Inc. (California) (ALMR)

28.96 -0.99 (-3.31%) USD  |  NASDAQ  |  Sep 09, 16:00
28.88 -0.08 (-0.28%) After-Hours: 20:00
More

Alamar Biosciences Financial Debt to Equity (Quarterly)

Financial Debt to Equity (Quarterly) Chart

View Financial Debt to Equity (Quarterly) for ALMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Financial Debt to Equity (Quarterly) Chart
Start Trial

Historical Financial Debt to Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --

Financial Debt to Total Equity Definition

Financial Debt to Total Equity is the amount of financial debt a company has over its total equity (Market Cap + Preferred Stock).

Read full definition.

Financial Debt to Equity (Quarterly) Range, Past 5 Years

View Financial Debt to Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Financial Debt to Equity (Quarterly) Benchmarks

View Financial Debt to Equity (Quarterly) Benchmarks
Start Trial
10X Genomics, Inc. Upgrade
Personalis, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Adaptive Biotechnologies Corp. Upgrade
Champions Oncology, Inc. Upgrade